- Investing Ideas
- /
- Danish Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Danish Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Results
4
High return on equity, past performance and sound balance sheet.
4 companies
ChemoMetec
Market Cap: DKK 13.6b
Engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally.
CHEMM
DKK 779.00
7D
14.1%
1Y
90.8%
Genmab
Market Cap: DKK 114.4b
A biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.
GMAB
DKK 1,859.00
7D
-3.2%
1Y
19.5%
Gubra
Market Cap: DKK 6.9b
A biotech company, focuses on the pre-clinical contract research and peptide-based drug discovery within metabolic and fibrotic diseases in Europe, North America, and internationally.
GUBRA
DKK 421.60
7D
-0.5%
1Y
-5.9%
Zealand Pharma
Market Cap: DKK 32.8b
A biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States.
ZEAL
DKK 465.80
7D
1.9%
1Y
-42.7%